The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To date, there is no effective therapeutic approach for treating SARS-CoV-2 infections. MicroRNAs (miRNAs) have been recognized to target the viral genome directly or indirectly, thereby in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jiulue, Stojanović, Jelena, Yasamineh, Saman, Yasamineh, Pooneh, Karuppannan, Sathish Kumar, Hussain Dowlath, Mohammed Junaid, Serati-Nouri, Hamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286877/
https://www.ncbi.nlm.nih.gov/pubmed/34278528
http://dx.doi.org/10.1007/s00705-021-05152-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286877/
https://www.ncbi.nlm.nih.gov/pubmed/34278528
http://dx.doi.org/10.1007/s00705-021-05152-5

Ejemplares similares